share_log

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

周一盘后交易时段,12只医疗保健股走势
Benzinga ·  2023/07/17 17:32

Gainers

获胜者

  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 89.5% to $0.5 during Monday's after-market session. At the close, Aridis Pharmaceuticals's trading volume reached 8.1 million shares. This is 212.0% of its average volume over the last 100 days. The company's market cap stands at $18.0 million.
  • Dare Bioscience (NASDAQ:DARE) stock moved upwards by 7.72% to $0.92. The company's market cap stands at $79.3 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock rose 6.53% to $1.63. Trading volume for this security closed at 514.4K, accounting for 17.8% of its average full-day volume over the last 100 days. The company's market cap stands at $185.8 million.
  • Cue Health (NASDAQ:HLTH) stock rose 5.45% to $0.45. The company's market cap stands at $67.9 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock rose 5.17% to $1.22. The company's market cap stands at $12.1 million.
  • Petros Pharma (NASDAQ:PTPI) shares rose 4.98% to $3.58. The company's market cap stands at $7.5 million.
  • 阿里迪斯制药 纳斯达克股票代码:ARDS)股价在周一的盘后交易时段上涨了89.5%,至0.5美元。收盘时,Aridis Pharmicals的交易量达到810万股。这是其过去100天平均成交量的212.0%。该公司的市值为1,800万美元。
  • 大胆生物科学 纳斯达克股票代码:DARE)股价上涨7.72%,至0.92美元。该公司的市值为7,930万美元。
  • Karyopharm Therape 纳斯达克股票代码:KPTI)股价上涨6.53%,至1.63美元。该证券的交易量收于514.4万,占其过去100天平均全日交易量的17.8%。该公司的市值为1.858亿美元。
  • 提示健康 纳斯达克股票代码:HLTH)股价上涨5.45%,至0.45美元。该公司的市值为6,790万美元。
  • 有氧诊断控股公司 纳斯达克股票代码:CDIO)股价上涨5.17%,至1.22美元。该公司的市值为1,210万美元。
  • 彼得罗斯制药 纳斯达克股票代码:PTPI)股价上涨4.98%,至3.58美元。该公司的市值为750万美元。

Losers

失败者

  • 9 Meters Biopharma (NASDAQ:NMTR) shares fell 60.0% to $0.25 during Monday's after-market session. 9 Meters Biopharma's trading volume hit 886.9K shares by close, accounting for 1142.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.6 million.
  • Masimo (NASDAQ:MASI) stock fell 24.92% to $110.5. Masimo's trading volume hit 84.8K shares by close, accounting for 18.1% of its average volume over the last 100 days. The company's market cap stands at $5.8 billion.
  • CEL-SCI (AMEX:CVM) shares fell 21.33% to $2.25. At the close, CEL-SCI's trading volume reached 388.8K shares. This is 210.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $100.6 million.
  • EUDA Health Holdings (NASDAQ:EUDA) stock fell 16.41% to $0.51. This security traded at a volume of 1.1 million shares come close, making up 248.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $12.6 million.
  • First Wave BioPharma (NASDAQ:FWBI) shares decreased by 16.08% to $0.68. This security traded at a volume of 153.5K shares come close, making up 8.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
  • Acumen Pharmaceuticals (NASDAQ:ABOS) stock declined by 9.68% to $8.78. Acumen Pharmaceuticals's trading volume hit 12.7 million shares by close, accounting for 4221.5% of its average volume over the last 100 days. The company's market cap stands at $360.2 million. See Also:
  • 9 米特生物制药 纳斯达克股票代码:NMTR)股价在周一的盘后交易时段下跌60.0%,至0.25美元。9 Meters Biopharma的交易量收盘时达到886.9万股,占其过去100天平均成交量的1142.9%。他们已发行股票的市值为360万美元。
  • Masimo 纳斯达克股票代码:MASI)股价下跌24.92%,至110.5美元。收盘时,Masimo的交易量达到84.8万股,占其过去100天平均交易量的18.1%。该公司的市值为58亿美元。
  • CEL-SCI (AMEX: CVM) 股价下跌21.33%,至2.25美元。收盘时,CEL-SCI的交易量达到38.8万股。这是其过去100天平均交易量的210.0%。他们已发行股票的市值为1.006亿美元。
  • EUDA 健康控股公司 纳斯达克股票代码:EUDA)股价下跌16.41%,至0.51美元。该证券的交易量接近110万股,占其过去100天平均交易量的248.7%。他们已发行股票的市值为1,260万美元。
  • 第一波生物制药 纳斯达克股票代码:FWBI)股价下跌16.08%,至0.68美元。该证券的交易量接近15.35万股,占其过去100天平均交易量的8.9%。他们已发行股票的市值为280万美元。
  • 敏锐制药 纳斯达克股票代码:ABOS)股价下跌9.68%,至8.78美元。截至收盘,Acumen Pharmicals的交易量达到1,270万股,占其过去100天平均成交量的4221.5%。该公司的市值为3.602亿美元。 另请参阅:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发